# A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period Dyskinesias

> **NCT01172379** · PHASE2 · COMPLETED · sponsor: **Eisai Limited** · enrollment: 2 (—)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** E2007
- **DRUG:** E2007
- **DRUG:** E2007
- **OTHER:** Placebo Comparator

## Key facts

- **NCT ID:** NCT01172379
- **Lead sponsor:** Eisai Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2005-02
- **Final completion:** —
- **Target enrollment:** 2 (—)
- **Last updated:** 2014-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01172379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01172379, "A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period Dyskinesias". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01172379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*